XML 37 R26.htm IDEA: XBRL DOCUMENT v3.3.1.900
Stockholders' Equity (Details Narrative) - USD ($)
1 Months Ended 3 Months Ended 6 Months Ended
Feb. 28, 2015
Jun. 30, 2008
Oct. 31, 2015
Jul. 29, 2015
Oct. 31, 2014
Oct. 31, 2015
Oct. 31, 2014
Stockholders' Equity              
Stock options granted, term           3 years 1 month  
Warrants              
Stockholders' Equity              
Stock warrants outstanding     3,358,275     3,358,275  
Warrants | Minimum              
Stockholders' Equity              
Exercise price of warrants     $ 2.00     $ 2.00  
Warrants | Maximum              
Stockholders' Equity              
Exercise price of warrants     $ 13.56     $ 13.56  
Stock-Based Compensation              
Stockholders' Equity              
Stock options granted     72,000     238,667  
Stock based compensation expense     $ 22,000   $ 5,000 $ 185,000 $ 9,000
Unrecognized compensation expense     $ 34,000     $ 34,000  
Unrecognized compensation expense, period for recognition           22 months  
Stock Options              
Stockholders' Equity              
Stock options granted   8,333          
Stock options granted, fair value at date of grant   $ 15.60          
Stock options granted, term   10 years          
Chief Executive Officer              
Stockholders' Equity              
Common shares surrendered           7,265  
Securities Purchase Agreement | Accredited Investors              
Stockholders' Equity              
Shares of stock sold       500,000      
Sale of stock, price per share       $ 1.00      
Sale of stock, value       $ 500,000      
Restricted stock issued, shares     25,000     54,667  
Restricted stock issued, value     $ 38,000     $ 88,000  
Preferred stock, call features           In September 2015, as a condition of the sale of the approximately 400,000 remaining shares of Series A Stock held by Isaac Capital Group to a group of independent accredited investors, all the residual call options were removed from the Preferred Series A Stock Purchase Agreements.  
Private Placement              
Stockholders' Equity              
Series A preferred stock converted           102,000  
Common stock issued upon conversion of Series A preferred stock           510,000  
Reduction of preferred stock upon conversion, value           $ 302,000  
Adjustment to additional paid in capital upon redemption of preferred stock           $ 208,000  
Series A preferred stock and warrants issued     20,000     20,000  
Proceeds from issuance of Series A preferred stock and warrants           $ 100,000  
Private placement, description On November 12, 2014 and February 2, 2015, the Company completed a private placement of an aggregate of 626,600 shares of its Series A Preferred Stock (“Series A Stock”) together with warrants to purchase shares of its common stock (“Preferred Warrant”) at a price of $5.00 per share, in accordance with the Series A Preferred Stock Purchase Agreement dated October 20, 2014 (the “Purchase Agreement”). From the date of respective closings and prior to October 20, 2019 (the “Put/Call Exercise Period”), the investors may exercise a right to purchase and require the Company to sell up to an additional 673,400 shares of Series A Stock. If the investors have not exercised this right during the Put/Call Exercise Period, the Company may exercise a right to cause and require the investors to purchase up to an additional 673,400 shares of Series A Stock, for an aggregate purchase price of $3,367,000. In September 2015, all the residual call options were removed from the Preferred Series A Stock Purchase Agreements.            
Private placement, conversion terms Holders of the Series A Stock shall initially have the right to convert such shares of Series A Stock into the number of authorized but previously unissued shares of the Company’s common stock obtained by dividing the stated value of each share of Series A ($5.00) by $2.00. For each share of Series A Stock, the investors will receive 2.5 Preferred Warrants to purchase the Company’s common stock at an exercise price of $2.50 per share. The Preferred Warrants are exercisable immediately for a period of five years from the date of closing. The exercise price of the Preferred Warrants is subject to adjustments in the case of stock splits, stock dividends, combinations of shares and similar recapitalization transactions. The exercisability of the Preferred Warrants may be limited if upon exercise, the warrant holder or any of its affiliates would beneficially own more than 4.99% of the Company’s Common Stock.            
Private placement preferred shares issued 626,600            
Proceeds from issuance of private placement $ 2,833,000            
Preferred stock, dividend rate, percentage 8.00%            
Preferred stock, dividend rate, per share dollar amount $ 0.40            
Preferred stock, dividends recorded     $ 59,000     $ 122,000  
Common stock issued for accumulated dividends     92,456        
Accumulated dividends, settled through issuance of stock     $ 174,000        
Adjustment to additional paid in capital, settlement of dividends     $ 82,000        
Price per share $ 5.00